These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 17761916)
41. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Heeschen C; Hamm CW; Laufs U; Snapinn S; Böhm M; White HD; Circulation; 2002 Mar; 105(12):1446-52. PubMed ID: 11914253 [TBL] [Abstract][Full Text] [Related]
42. Impact of early statin therapy in patients with ischemic stroke or transient ischemic attack. Chen PS; Cheng CL; Kao Yang YH; Yeh PS; Li YH Acta Neurol Scand; 2014 Jan; 129(1):41-8. PubMed ID: 23758549 [TBL] [Abstract][Full Text] [Related]
44. Dose-related effect of statins on atrial fibrillation after cardiac surgery. Kourliouros A; De Souza A; Roberts N; Marciniak A; Tsiouris A; Valencia O; Camm J; Jahangiri M Ann Thorac Surg; 2008 May; 85(5):1515-20. PubMed ID: 18442529 [TBL] [Abstract][Full Text] [Related]
45. Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial. Leone AM; Rutella S; Giannico MB; Perfetti M; Zaccone V; Brugaletta S; Garramone B; Niccoli G; Porto I; Liuzzo G; Biasucci LM; Bellesi S; Galiuto L; Leone G; Rebuzzi AG; Crea F Int J Cardiol; 2008 Nov; 130(3):457-62. PubMed ID: 18667247 [TBL] [Abstract][Full Text] [Related]
46. Effect of in-hospital initiation of lipid-lowering therapy on six-month outcomes in patients with acute ischemic stroke or transient ischemic attack. Yeh PS; Lin HJ; Bai CH; Hsieh FI; Ke DS; Li YH; Am J Cardiol; 2010 May; 105(10):1490-4. PubMed ID: 20451701 [TBL] [Abstract][Full Text] [Related]
47. [High-dose statin in ischemic stroke reduces the risk of recurrent stroke]. Crisby M; Olsson AG Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3541-3. PubMed ID: 19133582 [No Abstract] [Full Text] [Related]
48. High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease. Stoekenbroek RM; Boekholdt SM; Fayyad R; Laskey R; Tikkanen MJ; Pedersen TR; Hovingh GK; Heart; 2015 Mar; 101(5):356-62. PubMed ID: 25595417 [TBL] [Abstract][Full Text] [Related]
49. Statin treatment after a recent TIA or stroke: is effectiveness shown in randomized clinical trials also observed in everyday clinical practice? Lingsma HF; Steyerberg EW; Scholte op Reimer WJ; van Domburg R; Dippel DW; Acta Neurol Scand; 2010 Jul; 122(1):15-20. PubMed ID: 20047571 [TBL] [Abstract][Full Text] [Related]
50. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. Ray KK; Cannon CP; McCabe CH; Cairns R; Tonkin AM; Sacks FM; Jackson G; Braunwald E; J Am Coll Cardiol; 2005 Oct; 46(8):1405-10. PubMed ID: 16226162 [TBL] [Abstract][Full Text] [Related]
51. High cholesterol levels are associated with improved long-term survival after acute ischemic stroke. Markaki I; Nilsson U; Kostulas K; Sjöstrand C J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):e47-53. PubMed ID: 24103674 [TBL] [Abstract][Full Text] [Related]
52. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome. Fuentes B; Martínez-Sánchez P; Díez-Tejedor E Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842 [TBL] [Abstract][Full Text] [Related]
53. Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke. Tsivgoulis G; Kadlecová P; Kobayashi A; Czlonkowska A; Brozman M; Švigelj V; Csiba L; Kõrv J; Demarin V; Vilionskis A; Jatuzis D; Katsanos AH; Rudolf J; Krespi Y; Mikulik R Stroke; 2015 Sep; 46(9):2681-4. PubMed ID: 26173726 [TBL] [Abstract][Full Text] [Related]
54. Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials. Bangalore S; Fayyad R; Hovingh GK; Laskey R; Vogt L; DeMicco DA; Waters DD; Am J Cardiol; 2014 Jun; 113(12):2018-20. PubMed ID: 24793673 [TBL] [Abstract][Full Text] [Related]
55. Randomized Controlled Trial of Early Versus Delayed Statin Therapy in Patients With Acute Ischemic Stroke: ASSORT Trial (Administration of Statin on Acute Ischemic Stroke Patient). Yoshimura S; Uchida K; Daimon T; Takashima R; Kimura K; Morimoto T; Stroke; 2017 Nov; 48(11):3057-3063. PubMed ID: 29030478 [TBL] [Abstract][Full Text] [Related]
56. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. Versmissen J; Oosterveer DM; Yazdanpanah M; Defesche JC; Basart DC; Liem AH; Heeringa J; Witteman JC; Lansberg PJ; Kastelein JJ; Sijbrands EJ BMJ; 2008 Nov; 337():a2423. PubMed ID: 19001495 [TBL] [Abstract][Full Text] [Related]
57. Atorvastatin withdrawal elicits oxidative/nitrosative damage in the rat cerebral cortex. de Oliveira CV; Funck VR; Pereira LM; Grigoletto J; Rambo LM; Ribeiro LR; Royes LF; Furian AF; Oliveira MS Pharmacol Res; 2013 May; 71():1-8. PubMed ID: 23428346 [TBL] [Abstract][Full Text] [Related]
58. Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets. McCormack T; Harvey P; Gaunt R; Allgar V; Chipperfield R; Robinson P; Int J Clin Pract; 2010 Jul; 64(8):1052-61. PubMed ID: 20487050 [TBL] [Abstract][Full Text] [Related]
59. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
60. [Important aim of statin therapy: ischemic cardiovascular event (stroke)]. Császár A Ideggyogy Sz; 2008 Jul; 61(7-8):239-43. PubMed ID: 18763479 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]